RANTES augments radical oxygen products from eosinophils

Area of Science:

• Immunology
• Cell Biology
• Allergic Inflammation Research

Background:

• RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) is an 8-kD cytokine released by activated platelets.
• RANTES exhibits chemotactic activity, attracting eosinophils to sites of inflammation.
• Eosinophils play a role in allergic inflammatory responses.

Purpose of the Study:

• To investigate the effect of RANTES on radical oxygen product (ROS) generation by eosinophils.
• To elucidate the role of platelet-derived RANTES in eosinophil activation and allergic inflammation.

Main Methods:

• Eosinophil cell lines (EoL-1, EoL-3) and primary human eosinophils were used.
• Cells were stimulated with A23187 ionophore.
• Luminol-dependent chemiluminescence assay was employed to measure ROS production.
• RANTES treatment was administered to assess its impact on ROS generation.

Main Results:

• RANTES treatment significantly enhanced the peak and integrated values of ROS production in EoL-3 cells stimulated with A23187.
• Similar enhancement of ROS production was observed in EoL-1 cells and primary eosinophils upon RANTES treatment.
• These findings indicate RANTES activates eosinophils, leading to increased ROS release.

Conclusions:

• Platelets, through the release of RANTES, play a significant role in allergic inflammation.
• RANTES contributes to allergic pathogenesis by facilitating selective eosinophil infiltration and activation.
• Platelet-derived RANTES is a key mediator in amplifying eosinophil-driven inflammatory responses.